• SENSEX 82,188.99
    746.95 (+0.92%)
  • BANKNIFTY 56,578.40
    817.55 (+1.47%)
  • Cochin Shipyard
    2,547.25 2,977.10(%)
  • Azad Engineering
    1,561.00 1,128.40(%)
  • Garden Reach Sh.
    3,199.05 1,180.10(%)
  • HDFC Bank
    1,996.30 1,996.30(%)
  • Reliance Industr
    1,451.35 1,608.95(%)
  • Reliance Power
    63.13 63.39(%)
  • Natl. Aluminium
    190.90 263.10(%)
  • HFCL
    92.19 171.00(%)
  • Ramkrishna Forg.
    674.40 1,064.00(%)
  • Suzlon Energy
    66.10 46.00(%)
  • IDFC First Bank
    72.25 84.50(%)
  • Sika Interplant
    1,265.00 399.96(%)
  • Multi Comm. Exc.
    7,529.95 7,529.95(%)
  • St Bk of India
    816.45 898.80(%)
  • Mazagon Dock
    3,380.30 1,417.20(%)
  • Hindustan Zinc
    510.75 717.10(%)
  • ICICI Bank
    1,461.95 1,471.10(%)
  • REC Ltd
    417.30 653.90(%)
  • Eternal Ltd
    264.10 304.50(%)
  • Bharat Electron
    389.05 240.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

SMS Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 25807.0
  • ISIN : INE812G01025
245.10 -4 (-1.74%)
  • As on 07 Jun 2025 (EOD)

  • Today’s Low

    243.95

  • Today’s High

    251.90

  • Open

    249.40

  • Perv Close

    249.45

  • 52W Low

    176.05

  • 52W High

    398.00

Key Indicators

  • P/E(TTM)

    31.82

  • Mar.Cap (₹Cr.)

    2,172.86

  • Div & Yield %

    0.16

  • Book Value(₹)

    75.92

  • Debt-Equity Ratio

    -1.74

  • AGM Date

    06-Jun-2025

  • EPS

    7.71

  • P/E Ratio

    31.82

Financials Ratios

  • Debt-Equity Ratio

    0.54

  • Mar.Cap (₹Cr.)

    2,172.86

  • RONW (%)

    9.87

  • ROCE (%)

    11.69

Score Board

  • Equity (₹ in Cr.)

    8.87

  • BV (₹)

    75.90

  • Sales( ₹ in Cr.)

    782.75

  • NP (in Cr.)

    68.38

  • NP Var(%)

    38.0

  • Div%

    40.0

  • CPS (₹)

    11.60

  • EPS (₹)

    7.70

  • Traded Value (₹ in Lakhs)

    2,175.08

  • 52 Week High

    398.00

  • 52 Week Low

    176.05

  • Price BSE

    245.0

  • Price NSE

    245.00

  • Market Capital( in Cr.)

    2,175.08

  • P/C Ratio

    21.10

  • P/E Ratio

    31.80

  • Price Vs.BV

    7.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 752.35 554.56 555.34 611.60 453.32 511.47
Excise Duty 43.08 32.51 35.47 48.43 41.37 46.56
Net Sales 709.27 522.05 519.87 563.17 411.95 464.91
Other Income 4.46 4.91 5.20 3.45 5.11 3.40
Stock Adjustments 1.00 -36.08 112.50 -26.73 13.14 14.48
Total Income 714.73 490.88 637.57 539.89 430.20 482.79
EXPENDITURE :            
Raw Materials 425.04 299.52 387.80 313.27 259.50 307.19
Power and Fuel Cost 47.12 35.97 32.58 23.31 18.99 21.75
Employee Cost 56.78 50.08 51.02 41.17 39.35 35.59
Other Manufacturing Expenses 26.52 17.86 22.63 16.19 14.86 13.19
Selling and Administration Expenses 35.68 25.28 21.12 19.02 10.18 9.84
Miscellaneous Expenses 2.14 2.51 2.46 2.34 2.18 1.69
Employee Benefit Expenses 56.78 50.08 51.02 41.17 39.35 35.59
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 593.28 431.23 517.61 415.31 345.06 389.25
Operating Profit 121.45 59.65 119.97 124.59 85.14 93.55
Interest 23.60 21.97 19.16 11.19 12.32 11.92
Gross Profit 97.85 37.68 100.81 113.40 72.82 81.63
Depreciation 31.52 32.13 32.15 22.28 22.07 19.27
Profit Before Tax 66.33 5.55 68.66 91.12 50.75 62.36
Current Tax 15.13 0.00 14.92 16.05 8.94 13.33
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.78 1.47 -14.30 14.11 9.13 7.57
Reported Net Profit 49.42 4.08 68.04 60.96 32.69 41.45
Extraordinary Items 0.03 -0.04 0.00 -0.01 -0.03 0.00
Adjusted Net Profit 49.39 4.12 68.04 60.97 32.72 41.45
Adjustment below Net Profit -0.07 -0.21 0.04 -0.16 -0.09 -0.08
P & L Balance brought forward 322.22 320.88 265.35 214.55 197.05 168.23
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 12.54 2.54 12.54 10.00 15.10 12.55
P & L Balance carried down 359.04 322.22 320.88 265.35 214.55 197.05
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 40.00 30.00 30.00 30.00 25.00 25.00
Dividend Per Share(Rs) 0.40 0.30 0.30 0.30 0.25 0.25
Earnings Per Share-Unit Curr 5.84 0.48 8.04 7.20 3.86 4.90
Earnings Per Share(Adj)-Unit Curr 5.84 0.48 8.04 7.20 3.86 4.90
Book Value 64.02 58.49 58.33 50.59 43.40 40.16
Book Value(Adj)-Unit Curr 64.02 58.49 58.33 50.59 43.40 40.16

Shareholding Pattern

  • Promoter Group

    66.26%

  • Public Share Holding

    33.74%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,120,320 1.26 1,120,320 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 48,678,270 54.91 46,178,270 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 58,745,010 66.26 54,745,010 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 71,041 0.08 71,041 7
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,154,962 2.43 2,154,962 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 400 0.00 400 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,226,403 2.51 2,226,403 11
2] Non Institution
Bodies Corporate 1,421,336 1.60 1,421,236 102
Clearing Members 226 0.00 226 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,240,283 2.53 2,239,383 390
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,865,409 6.62 5,865,409 8
Individuals holding nominal share capital up to Rs. 1 lakh 17,494,500 19.73 17,272,919 34,807
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 658,363 0.74 658,363 4
Sub Total 27,680,617 31.22 27,458,036 35,314
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 88,652,030 100.00 84,429,449 35,332

Company Background

SMS Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs

  • SMS Pharmaceuticals Ltd
  • BSE Code : 25807.0
  • ISIN : INE812G01025

  • Incorporation Year

    1987

  • Registered Office

    19 III Rd 71 Opp Bharatividya
    Bhavan Public Sch Jubilee Hill, Hyderabad,
    Telangana-500096

  • Telephone

    91-40-66288888

  • FAX

    91-40-23551401

  • Chairman

    P Ramesh Babu

  • Managing Director

    P Ramesh Babu

  • Company Secretary

    Thirumalesh Tumma

  • Auditor

    Suryanarayana & Suresh

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285 Domalguda,
    ,
    Mumbai - Hyderabad - 500 029

SMS Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
SMS Pharma. 245.35 713.72 752.35 31.82 11.22
Abbott India 31,751.10 6,097.18 5,848.91 47.70 44.71
Astrazeneca Phar 9,791.90 1,330.33 1,295.53 211.49 33.26
P & G Health Ltd 5,550.45 1,166.89 1,151.26 36.68 39.76
Glaxosmi. Pharma 3,431.50 3,866.05 3,723.49 63.25 58.72
Cipla 1,503.75 17,645.00 16,574.34 23.55 20.10
Amrutanjan Healt 714.85 437.58 421.23 40.66 20.84
Guj. Themis Bio. 322.55 174.19 169.82 72.00 44.82
Fermenta Biotec. 321.90 315.24 307.09 14.01 4.10
Bliss GVS Pharma 136.50 638.96 605.46 20.84 11.19
Ambalal Sarabhai 35.88 11.70 3.81 33.22 1.92